Paper · 38851997

EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).

European Association for the Study of the Liver (EASL) and 2 others. J Hepatol, 2024. Cited by 1,919 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Papers, record 38851997. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38851997

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).; PubMed
Journal: J Hepatol; PubMed
Year: 2024; PubMed
Publication types: Journal Article, Practice Guideline; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/38851997/; PubMed
DOI: https://doi.org/10.1016/j.jhep.2024.04.031; PubMed
The journal: https://conductscience.org/library/journal-index/8503886; PubMed
Citations, by iCite: 1,919; iCite
Relative citation ratio, by iCite: 353.94, provisional; iCite
Revised in PubMed: 2026-05-18; PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Kind
1	European Association for the Study of the Liver (EASL)	Group
2	European Association for the Study of Diabetes (EASD)	Group
3	European Association for the Study of Obesity (EASO)	Group

Source PubMed

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Non-alcoholic Fatty Liver Disease	Major topic
Humans
Obesity

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials7

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

Trial	Title	The trial lists it as	Source
NCT06940375	Incidence of Liver Disease-Related Outcomes in People With HIV	Results	ClinicalTrials.gov
NCT07475962	Prevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 Diabetes	Background	ClinicalTrials.gov
NCT07503431	Effect of Plant-based Diets on Liver Biomarkers, Cardiometabolic Health, and Exposure to Environmental Contaminants and Endocrine Disruptors in Patients With Metabolic Liver Disease.	Background	ClinicalTrials.gov
NCT07513168	Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults	Background	ClinicalTrials.gov
NCT07658755	Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme	Background	ClinicalTrials.gov
NCT07663188	FIB-4 Cut-Offs for Liver Fibrosis in Obese Endocrinology Patients	Background	ClinicalTrials.gov
NCT07731360	Non-Invasive Diagnostic Panel for MASLD in Children With Obesity	Results	ClinicalTrials.gov

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by1,401

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,919 citations.

PMID	Title	Journal	Year	In Papers	Source
42,985,147	Metabolic dysfunction-associated steatotic liver disease: Pathogenesis, complications and pharmacological treatment.	EXCLI J	2026	https://conductscience.org/library/papers/42985147	PubMed
42,984,759	Commentary: Wogonoside alleviates metabolic dysfunction-associated steatohepatitis by modulating AMPK and xCT/GPX4 pathways to restrain lipid dysregulation and ferroptosis.	Front Pharmacol	2026	https://conductscience.org/library/papers/42984759	PubMed
42,983,650	Association between the red blood cell distribution width to albumin ratio and cardiovascular outcomes in MASLD patients: a national cohort study integrating machine learning.	BMC Cardiovasc Disord	2026	https://conductscience.org/library/papers/42983650	PubMed
42,983,401	Fatty liver index-defined hepatic steatosis and impaired fasting glucose differentially associate with incident diabetes and cardiovascular events in older adults: a nationwide cohort study.	Cardiovasc Diabetol	2026	https://conductscience.org/library/papers/42983401	PubMed
42,978,695	Diabesity: an old term, a modern challenge - multi-omics and precision anti-obesity pharmacotherapy in type 2 diabetes.	J Pharm Pharm Sci	2026	https://conductscience.org/library/papers/42978695	PubMed
42,977,998	Complication Prevention Beyond Glycaemic Control in Type 2 Diabetes: Cumulative Metabolic Exposure, Organ Vulnerability and Treatment Durability.	Endocrinol Diabetes Metab	2026	https://conductscience.org/library/papers/42977998	PubMed
42,977,476	Diagnostic Performance of Magnetic Resonance Elastography Versus Vibration-Controlled Transient Elastography for Liver Fibrosis Staging in Steatotic Liver Disease.	NMR Biomed	2026	https://conductscience.org/library/papers/42977476	PubMed
42,968,831	Baseline monocyte SGLT2 mRNA expression and changes in the fibrosis-4 index after luseogliflozin treatment in participants with type 2 diabetes and MASLD.	Diabetol Int	2027	https://conductscience.org/library/papers/42968831	PubMed
42,968,028	Regional brain morphometric correlates of CT-defined metabolic dysfunction-associated steatotic liver disease and hepatic fat burden.	BMC Med Imaging	2026	https://conductscience.org/library/papers/42968028	PubMed
42,966,860	Cumulative estimated glucose disposal rate and longitudinal eGDR patterns in relation to incident cardiovascular disease among middle-aged and older adults with metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.	Cardiovasc Diabetol	2026	https://conductscience.org/library/papers/42966860	PubMed

1 to 10 of 1,401

See all 1,401 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38851997

GET https://conductscience.org/api/papers/v1/38851997/cited_by?page=2

API reference For AI assistants